Nutex Health Inc (NUTX) financials
Nutex Health revenue and earnings by year
Nutex Health's revenue was $875 million in the fiscal year to December 31, 2025, up 82.4% from the year before. Net income was $70.8 million, 8.1% of revenue. Since the fiscal year to December 31, 2020, revenue has grown 26.1% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 6 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
| Revenue | 875 | 480 | 248 | 219 | 332 | 274 |
| Revenue growth | 82.4% | 93.8% | 12.9% | -33.9% | 21.0% | — |
| Gross profit | 444 | 196 | 35 | 15 | 179 | 158 |
| Gross margin | 50.8% | 40.9% | 14.0% | 7.0% | 54.1% | 57.5% |
| Operating income | 276 | 131 | -32 | -407 | 170 | 153 |
| Operating margin | 31.5% | 27.2% | -12.8% | -185.4% | 51.4% | 55.9% |
| Net income | 71 | 52 | -46 | -425 | 133 | 106 |
| Net margin | 8.1% | 10.9% | -18.5% | -193.7% | 40.0% | 38.7% |
| Diluted EPS | $10.48 | $9.25 | -$10.71 | -$94.50 | — | — |
| Free cash flow | 246 | 21 | -8 | 36 | 137 | 25 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open NUTX in Markets.
See also: NUTX valuation and P/E history · NUTX returns
No forecast, no recommendation. This page describes Nutex Health Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.